Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB

The positive EndTB-Q trial results were shared at the Union conference. They showed

that a BCDL regimen is successful in treating less severe MDR TB in 6-9 months, when

compared to the longer WHO regimen. The longer WHO regimen still remains more

successful in severe cases. Read more here.